Phinest Cannabis partners with Symbiotic Genetics

Phinest Cannabis entered a new licensing agreement with Symbiotic Genetics. Under the agreement, Phinest Nursery is granted a license for two cannabis cultivars, one exclusively, for sale to licensed cultivators and retailers throughout California.

Symbiotic Genetics is excited to team up with Phinest, the pioneer of commercial cannabis tissue culture, said Trey Ish, president of Symbiotic Sacramento. Our agreement allows for our premium genetics to be delivered as vigorous, disease-free plants to both home and commercial growers throughout California. The Phinest nursery catalog adds Orange Malt and Amarelo 9 strains to the Orange Malt and Amarelo 9 strains.

Matthew Wich, COO of Phinest Cannabis stated, Working with Symbiotic and bringing their strains to market through our nursery platform builds on Phinest's reputation as a purveyor of elite cannabis cultivars. We are very excited to be working with another Sacramento-based cannabis company and look forward to this licensing agreement as the beginning of a strong locally-rooted relationship. Phinest Cannabis and Symbiotic Genetics will be co-sponsoring this year's Emerald Cup Harvest Ball in Santa Rosa, California on December 2022 in Building B Booth 129 to showcase their teams' work.

Phinest Cannabis' mission is to empower commercial cannabis growers and home growers with 100% disease free, generation zero tissue culture clones and teens. Since 2018, Phinest has produced millions of healthy cannabis clones and recently opened a cannabis tissue culture nursery capable of producing 18 million clones per year.

Get your daily dose of cannabis news on Benzinga Cannabis.